NCT06467383

A Study to Describe the Diagnostic and Therapeutic Path of Patients with NSCLC in Early Stage and Locally Advanced

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 600 (estimated)
• Sponsor: MSD Italia S.r.l. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a non-interventional, retrospective observational study to improve knowledge regarding the diagnosis and treatments of patients who have/had non-small cell lung cancer (NSCLC), either early stage (stage I-II).

Detailed description

Due to heterogeneity of patients with stage I-III Non Small Cell Lung Cancer (NSCLC), there is not a unique common therapeutic approach and there is no consensus about the optimal timing, sequencing and combination of surgery, chemotherapy and radiotherapy across the spectrum of early stage and locally advance disease. Consequently, the choice of local treatment modality can vary across countries and centers.

Conditions

• Non-small Cell Lung Cancer
• NSCLC
• NSCLC, Stage III
• NSCLC, Stage I

Timeline

• Start date: 2024-06-25
• Primary completion: 2025-06-24
• Completion: 2025-06-24
• First posted: 2024-06-21
• Last updated: 2025-01-14

Locations

25 sites across 1 country: Italy